Top compounds associated with response to LYPD2


Feature Type Standardized
Nominal ANOVA
mRNA PD173074 GDSC1000 pan-cancer AAC -0.076 0.03
mRNA semagacestat CTRPv2 pan-cancer AAC 0.077 0.03
mRNA BX-912 GDSC1000 pan-cancer AAC -0.063 0.04
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.071 0.04
mRNA BMS-536924 GDSC1000 pan-cancer AAC -0.067 0.04
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.1 0.04
mRNA PRL-3 Inhibitor I CTRPv2 pan-cancer AAC 0.076 0.04
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.06 0.05
mRNA AR-42 GDSC1000 pan-cancer AAC -0.06 0.05
mRNA XMD13-2 GDSC1000 pan-cancer AAC -0.062 0.05
Download CSV